- Home
- Publications
- Publication Search
- Publication Details
Title
Are new variants of psoriasis therapy (
IL
‐17 inhibitors) safe?
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF DERMATOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-06-13
DOI
10.1111/ijd.14509
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Psoriasis pathogenesis and the development of novel targeted immune therapies
- (2017) Jason E. Hawkes et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Secukinumab shows significant efficacy in palmoplantar psoriasis: Results from GESTURE, a randomized controlled trial
- (2017) Alice Gottlieb et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The effect of secukinumab on moderate-to-severe scalp psoriasis: Results of a 24-week, randomized, double-blind, placebo-controlled phase 3b study
- (2017) Jerry Bagel et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial
- (2017) Peter Nash et al. LANCET
- Impact of Ixekizumab Treatment on Depressive Symptoms and Systemic Inflammation in Patients with Moderate-to-Severe Psoriasis: An Integrated Analysis of Three Phase 3 Clinical Studies
- (2017) Christopher E.M. Griffiths et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Vitamin D and its role in psoriasis: An overview of the dermatologist and nutritionist
- (2017) Luigi Barrea et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Efficacy and safety of brodalumab in patients with generalized pustular psoriasis and psoriatic erythroderma: results from a 52-week, open-label study
- (2016) K. Yamasaki et al. BRITISH JOURNAL OF DERMATOLOGY
- A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis
- (2016) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Brodalumab, a human anti-interleukin-17-receptor antibody in the treatment of Japanese patients with moderate-to-severe plaque psoriasis: Efficacy and safety results from a phase II randomized controlled study
- (2016) Hidemi Nakagawa et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52-week, open-label, phase 3 study (UNCOVER-J)
- (2016) Hidehisa Saeki et al. JOURNAL OF DERMATOLOGY
- Environmental Risk Factors in Psoriasis: The Point of View of the Nutritionist
- (2016) Luigi Barrea et al. International Journal of Environmental Research and Public Health
- Nutrition: a key environmental dietary factor in clinical severity and cardio-metabolic risk in psoriatic male patients evaluated by 7-day food-frequency questionnaire
- (2015) Luigi Barrea et al. Journal of Translational Medicine
- Systemic Therapies for Psoriasis: An Evidence-Based Update
- (2014) Laura F. Sandoval et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Immunology of Psoriasis
- (2014) Michelle A. Lowes et al. Annual Review of Immunology
- In psoriasis, levels of hope and quality of life are linked
- (2014) Tomasz Hawro et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- The role of IL-17 in psoriasis
- (2014) Mona Malakouti et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Efficacy, safety and usability of secukinumab administration by autoinjector/pen in psoriasis: a randomized, controlled trial (JUNCTURE)
- (2014) C. Paul et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- An Observational Study on the Obesity and Metabolic Status of Psoriasis Patients
- (2013) Cho Rok Kim et al. Annals of Dermatology
- Treatment of Psoriasis and Psoriatic Arthritis
- (2013) Marina Papoutsaki et al. BIODRUGS
- IL-17 targeted therapies for psoriasis
- (2013) Andrea Chiricozzi et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Le psoriasis : physiopathologie et immunogénétique
- (2013) M. Ammar et al. PATHOLOGIE BIOLOGIE
- Classical to Current Approach for Treatment of Psoriasis: A Review
- (2012) Mahfoozur Rahman et al. Endocrine Metabolic & Immune Disorders-Drug Targets
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started